Vadastuximab Talirine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vadastuximab Talirine, covering 2018-12-12 to 2019-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients [Phase 1, Phase 2]